Latham & Watkins LLP represented the initial purchasers in the offering.Haemonetics Corporation (NYSE: HAE) priced its offering of US$435 million aggregate principal amount of 0% Convertible Senior…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
